Search results
Results from the WOW.Com Content Network
The risk of hepatocellular carcinoma in type 2 diabetics is greater (from 2.5 [14] to 7.1 [22] times the nondiabetic risk) depending on the duration of diabetes and treatment protocol. [23]
Hepatocellular carcinoma is associated with abdominal mass, abdominal pain, vomiting, anemia, back pain, jaundice, itching, weight loss and fever. [12] Treatment options may include surgery, targeted therapy and radiation therapy. [1] In certain cases, ablation therapy, embolization therapy or liver transplantation may be used. [1]
Cholangiocarcinoma, also known as bile duct cancer, is a type of cancer that forms in the bile ducts. [2] Symptoms of cholangiocarcinoma may include abdominal pain , yellowish skin , weight loss , generalized itching , and fever. [ 1 ]
Successful treatment decreases the future risk of hepatocellular carcinoma by 75%. [115] Before 2012, sustained response occurred in about 40–50% of those with HCV genotype 1 who received 48 weeks of treatment. [5] A sustained response was seen in 70–80% of people with HCV genotypes 2 and 3 following 24 weeks of treatment. [5]
Multiple endocrine neoplasia type 2 (also known as "Pheochromocytoma (codons 630 and 634) and amyloid producing medullary thyroid carcinoma", [1] "PTC syndrome," [1] and "Sipple syndrome" [1]) is a group of medical disorders associated with tumors of the endocrine system.
This is a list of countries by cancer frequency, as measured by the number of new cancer cases per 100,000 population among countries, based on the 2018 GLOBOCAN statistics and including all cancer types (some earlier statistics excluded non-melanoma skin cancer).
A Klatskin tumor (or hilar cholangiocarcinoma) is a cholangiocarcinoma (cancer of the biliary tree) occurring at the confluence of the right and left hepatic bile ducts. The disease was named after Gerald Klatskin, who in 1965 described 15 cases and found some characteristics for this type of cholangiocarcinoma. [1] [2] [3]
Multiple endocrine neoplasia type 2B (MEN 2B) is a genetic disease that causes multiple tumors on the mouth, eyes, and endocrine glands.It is the most severe type of multiple endocrine neoplasia, [2] differentiated by the presence of benign oral and submucosal tumors in addition to endocrine malignancies.